News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novartis India Limited (NVS) To Sell Anti-TB Bulk Drug Business To Sandoz Private Limited


10/19/2005 5:13:04 PM

Novartis India Ltd on Monday said that the members of the company has approved, proposal for sale of the it's Rifampicin bulk drug business with its unit located at Mahad, Maharashtra to Sandoz Pvt Ltd on a going concern basis for a consideration of Rs307.7mn, provided that the said consideration being suitably adjusted to represent any change in "net asset" value on the date of transaction.

Read at India Infoline

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES